InsidersTradesSigma
Browse the detailed record of transactions filed by Orwin John A, Chairman & CEO. Officer active across 3 companies, notably Travere Therapeutics, Inc.. In total, 8 disclosures have been published. The latest transaction was filed on 13 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
8 of 8 declarations
John A. Orwin is the President & CEO of Travere Therapeutics, Inc., Seagen Inc., and Atreca, Inc. He leads these companies with a strategic vision, overseeing operations and growth initiatives. John is responsible for implementing corporate strategies and managing stakeholder relationships. His experience in the biopharmaceutical sector is a valuable asset for the leadership of these organizations.